share_log

康希諾生物：董事辭任及建議委任董事

CANSINOBIO: RESIGNATION OF DIRECTORANDPROPOSED APPOINTMENT OF DIRECTOR

HKEX ·  May 31 18:51
Summary by Futu AI
康希諾生物股份公司宣佈，梁頴宇女士因個人工作原因將於2024年5月30日辭任非執行董事及提名委員會成員。梁女士確認與公司無意見分歧及無需特別提請股東注意的事項。同時，公司建議李志成先生接任非執行董事及提名委員會成員，待股東週年大會考慮及批准。李先生具豐富的生物醫藥行業經驗，曾於多家知名公司擔任高層職務，並在香港聯交所上市公司擔任過獨立非執行董事。董事會對梁女士在任期間的貢獻表示感謝，並期待李先生能為公司帶來新的貢獻。
康希諾生物股份公司宣佈，梁頴宇女士因個人工作原因將於2024年5月30日辭任非執行董事及提名委員會成員。梁女士確認與公司無意見分歧及無需特別提請股東注意的事項。同時，公司建議李志成先生接任非執行董事及提名委員會成員，待股東週年大會考慮及批准。李先生具豐富的生物醫藥行業經驗，曾於多家知名公司擔任高層職務，並在香港聯交所上市公司擔任過獨立非執行董事。董事會對梁女士在任期間的貢獻表示感謝，並期待李先生能為公司帶來新的貢獻。
CONXINO BIOLOGICS CO., LTD. ANNOUNCED THAT MS. LEUNG WING YU WILL RESIGN AS A NON-EXECUTIVE DIRECTOR AND MEMBER OF THE NOMINATING COMMITTEE ON 30 MAY 2024 DUE TO PERSONAL WORK REASONS. Ms. Leung confirms that there is no disagreement with the Company and that there is no need to bring any special attention to shareholders. AT THE SAME TIME, THE COMPANY PROPOSES THAT MR. LI ZHI-SHENG BECOME A NON-EXECUTIVE DIRECTOR AND A MEMBER OF THE NOMINATING COMMITTEE, PENDING CONSIDERATION AND APPROVAL BY THE ANNUAL GENERAL MEETING. Mr. Li has extensive experience in the biopharmaceutical industry and has held senior positions in several well-known companies and served as an independent non-executive director of listed companies on the Hong Kong Stock Exchange. The Board of Directors is grateful for Ms. Leung's contributions during her tenure and looks forward to Mr. Lee making new contributions to the Company.
CONXINO BIOLOGICS CO., LTD. ANNOUNCED THAT MS. LEUNG WING YU WILL RESIGN AS A NON-EXECUTIVE DIRECTOR AND MEMBER OF THE NOMINATING COMMITTEE ON 30 MAY 2024 DUE TO PERSONAL WORK REASONS. Ms. Leung confirms that there is no disagreement with the Company and that there is no need to bring any special attention to shareholders. AT THE SAME TIME, THE COMPANY PROPOSES THAT MR. LI ZHI-SHENG BECOME A NON-EXECUTIVE DIRECTOR AND A MEMBER OF THE NOMINATING COMMITTEE, PENDING CONSIDERATION AND APPROVAL BY THE ANNUAL GENERAL MEETING. Mr. Li has extensive experience in the biopharmaceutical industry and has held senior positions in several well-known companies and served as an independent non-executive director of listed companies on the Hong Kong Stock Exchange. The Board of Directors is grateful for Ms. Leung's contributions during her tenure and looks forward to Mr. Lee making new contributions to the Company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.